Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

PURMX Therapeutics

Explore full profile

Discovering therapeutic drugs that replenish small RNA molecules that are lacking in cells

Hiroshima, JapanFounded 2021Biotech & Life Sciences
Valuation $25–50M Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for PURMX Therapeutics and the history behind them.

About PURMX Therapeutics

PURMX Therapeutics is a biotechnology company focused on developing innovative nucleic acid medicines to treat various types of cancer. The company operates in the biopharmaceutical market, primarily serving patients with malignant pleural mesothelioma and other cancers. PURMX's business model revolves around the research, development, and clinical trials of its proprietary microRNA-based drugs. The company generates revenue through the commercialization of its drug pipeline, starting with its lead product, MIRX002. This product is currently undergoing first-in-human clinical trials at Hiroshima University. PURMX leverages its unique technology for diagnosing aging based on telomere G tail length and aims to turn on the aging of cancer cells to combat the disease. The company was founded in January 2021 and has quickly gained attention both domestically and internationally for its groundbreaking work in nucleic acid medicine.

Source: Dealroom company data

At a glance

Founded
2021
Headquarters
Hiroshima, Japan
Sector
Biotech & Life Sciences

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Hiroshima Venture Capital
  • UTEC - The University of Tokyo Edge Capital Partners
  • Mitsubishi UFJ Capital
  • Osaka University Venture Capital
  • QB Capital
  • Keio Innovation Initiative

Talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇯🇵 Japan100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about PURMX Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PURMX Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles